Please login to the form below

Not currently logged in
Email:
Password:

prescription medicines

This page shows the latest prescription medicines news and features for those working in and with pharma, biotech and healthcare.

Pfizer set to unveil Mylan merger and spin-off

Pfizer set to unveil Mylan merger and spin-off

The deal will help streamline Pfizer, focusing it around its more profitable prescription medicines division, and provide it with extra capital to spend on more bolt-on acquisitions – or something bigger – ... Pfizer has already done a deal with GSK

Latest news

  • Another setback on pricing as Trump drops rebate plans Another setback on pricing as Trump drops rebate plans

    The proposals are all aimed at lowering the cost of prescription medicines in the US, which are among the highest in the world and have risen well above inflation in recent ... spokesman. “President Trump will consider using any and all tools to ensure

  • Charity launches real-world medical cannabis study Charity launches real-world medical cannabis study

    Since then hundreds of thousands of patients have been forced to break the law to get a treatment that most find preferable to their previous prescription medicines.”. ... earlier this month even though she had a private prescription, on the grounds

  • Novartis and Sanofi heads take on UK pharma leadership roles Novartis and Sanofi heads take on UK pharma leadership roles

    Nevertheless, a flow of groundbreaking medicines, some encouraging bespoke access deal with NHS England, and a new five year pricing and access scheme is giving the sector cause for optimism. ... Haseeb Ahamad, president of the ABPI, said:  “We are

  • Europe’s medicines tracking system goes live Europe’s medicines tracking system goes live

    How the system works:. Pharmaceutical manufacturers and parallel importers will now serialise the packaging of their prescription medicines with a Unique Identifier (imbedded in a two-dimensional data-matrix), as well ... The verification of the Unique

  • End to middlemen rebates a major shift in US drug pricing End to middlemen rebates a major shift in US drug pricing

    The proposals are aimed at lowering the cost of prescription medicines in the US, which are among the highest in the world and have risen well above inflation in recent years. ... The changes fulfil promises made by President Trump last year as part of

More from news
Approximately 2 fully matching, plus 227 partially matching documents found.

Latest Intelligence

  • Pharmaceutical social media after Cambridge Analytica Pharmaceutical social media after Cambridge Analytica

    prescription-only medicines is illegal outside the United States or New Zealand, and some pharmaceutical marketers still choose to avoid risks of perceived product marketing by locking down social media engagement.

  • Legal and regulatory affairs

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    phrases. For healthcare companies, it was the same. However, it started to change when the ABPI established the Prescription Medicines Code of Practice Authority (PMCPA) in 1993 to operate the Code ... At the time, they knew the campaign would test the

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    If successful, however, these arrangements could be expanded to encompass a broader range of medicines. ... Bulgaria and Romania have been working together since 2014 to explore opportunities to reduce the prices they pay for their prescription medicines.

  • Market access improvements in Turkey Market access improvements in Turkey

    Almost the entire pharmaceutical market is made up of prescription medicines (93.8%) with 87% reimbursed. ... While welcoming the promise of a slight acceleration of review time with high priority medicines, industry is disappointed that orphan drugs and

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    He also brings experience form Boehringer Ingelheim, where he was director of its UK Change Project, head of UK market access for prescription medicines, and held a series of marketing management

  • Pink Carrots appoints art director Pink Carrots appoints art director

    Pink Carrots, which recently won the prescription medicines category at the GWA HealthCare Awards 2014, also made three other hires.

  • IPHA names Janssen's Dr Leisha Daly as president IPHA names Janssen's Dr Leisha Daly as president

    Daly, who has also been a member of IPHA's board of directors since June 2012, was reappointed to the Association's Prescription Medicines Division Strategy Board in August 2012.

  • Isgro boosts senior team Isgro boosts senior team

    Weber's healthcare agency experience ranges from prescription and over the counter medicines to veterinary medicine (both small and livestock). She studied Spanish and Portuguese literature at the Goethe Universität Frankfurt,

  • Boehringer names new UK MD Boehringer names new UK MD

    She has since held senior management roles at Boehringer across the globe, including spells as head of human pharma in Denmark, managing director in Turkey and head of prescription medicines and ... Most recently Krumins served at Boehringer's operations

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics